Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors

Euglycemic diabetic ketoacidosis (EDKA) is an emerging complication of diabetes associated with an increasing use of sodium-glucose transporter type 2 (SGLT-2) inhibitor drugs. This review highlights the growing incidence of EDKA and its diagnostic challenges due to the absence of hallmark hyperglyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Erica, Clement, Stephen, Garg, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical care/Education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551972/
https://www.ncbi.nlm.nih.gov/pubmed/37797963
http://dx.doi.org/10.1136/bmjdrc-2023-003666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551972/
https://www.ncbi.nlm.nih.gov/pubmed/37797963
http://dx.doi.org/10.1136/bmjdrc-2023-003666

Ejemplares similares